Health & Biotech
Creso Pharma (ASX:CPH) is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals.
Founded by a team of highly experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
It was the first company to import medical cannabis to Australia and it has a presence across Canada, under its subsidiary Mernova, Switzerland and the EU, Israel, Latin America and Australia.
From the outset, Creso’s goal has been to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Creso can deliver products with standardised dosing and formulations through the application of pharmaceutical rigour, Good Manufacturing Practices (GMP) standards when appropriate and proprietary, innovative delivery technologies.
As a global company, Creso is not limited by any single market. This enables Creso to offer a diverse portfolio of solutions to the widest possible population.
By partnering with leading global companies in critical areas of research and product development, manufacturing and distribution, Creso has been able to accelerate the development and distribution of approved products allowing for broad access by patients and consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Cannabis: Bod gets new import clearance from regulators; shares lag
Health & Biotech
Creso Pharma makes technological breakthrough for expansion of human health product line
Health & Biotech
Pet CBD is a huge market and one small cap is riding that wave
Health & Biotech
Creso Pharma beats 2.5m cannaQIX® lozenges sales milestone
Health & Biotech
Weed Week: Cannabis may be the answer for this wilting WA coal mining town
Health & Biotech
Creso hits new milestones: 3 million anibidiol® hemp oil pet doses given, books 700pc sales growth
News
Lunchtime ASX small cap wrap: Who’s feeding the pigs today?
News
Corporate: Australian Ethical has tripled this financial year after its latest update
Health & Biotech
African cannabis is overlooked, but it’s a multi-billion-dollar-market
Health & Biotech
Creso Pharma signs key commercial agreement as it expands global reach into the African market
Health & Biotech
Creso Pharma’s first Australian import has arrived and sales have already started
News
Lunchtime ASX small cap wrap: Who’s breaking a record or two today?
News
Hot Money Monday: These are the most in-demand stocks on the ASX right now
Health & Biotech
With M&A heating up in Aus cannabis, is it international land grab time?
Health & Biotech
Cannabis: THC just got those long-awaited narcotics licenses
Health & Biotech
Weed Week: There’s a wave of THC-related vaping illnesses sweeping the US
News